Pierre Strübin

Latshaw Enterprises, Inc. was a holding company which manufactures cable devices and electronic components. The company through its subsidiaries produced and marketed component parts for original equipment manufactures as well as consumer products. The company was founded in 1982 and headquartered in Wichita, KS.

BK Technologies, Inc. engages in the provision of two-way radio communications equipment. Its brands include BK Technologies, BK Radio and RELM. The company was founded in February 1960 and is headquartered in West Melbourne, FL.

ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA.

Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015.

CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA.

Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ.

Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York.

Abrika Pharmaceuticals, Inc. develops and manufactures generic pharmaceuticals. The firm engages in the formulation and commercialization of both controlled release and immediate release products. The company was founded by Alan Phillip Cohen in May 2002 and is headquartered in Sunrise, FL.

Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands.

Cedarburg Hauser Pharmaceuticals, Inc. is a pharmaceutical company. The company was founded by Charles M. Boland and James G. Yarger in 1997 and is headquartered in Grafton, WI.

Advantice Health LLC manufactures and supplies therapeutic medicines and personal products. It is engaged in the marketing, sale and distribution of over-the-counter (OTC) medicines to drug stores, food stores, mass merchandisers, health professionals and international markets. It is best known for podiatrist recommended Kerasal One-Step Exfoliating Moisturizer Therapy. The company was founded in 2004 and is headquartered in Cedar Knolls, NJ.

Headquartered in Houston, Sanders Morris Harris Group, Inc. (NADAQ: SMHG) invests in private equity through the SMH Private Equity Funds.

Alpex Pharma SA develops and produces orally dispersible tablet (ODT). Its products include Alpexicam and Meloxicam ODT. The firm also provides formulation development and contract manufacturing services. The company was founded in 1985 and is headquartered in Mezzovico, Switzerland.

Sanders Morris Harris LLC (Investment Management) (SMH-IM) is the investment management division of Sanders Morris Harris LLC, a registered broker/dealer firm headquartered in Houston, Texas. The firm was founded in 2000 and is a wholly-owned subsidiary of Tectonic Financial, Inc. (NASDAQ: TECTP). SMH-IM provides advisory services to individuals, pooled investments, plan sponsors, trusts, estates, corporations, institutions, and other businesses.

Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL.

Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland.

Pharmaceutics International, Inc. develops and manufactures pharmaceuticals dosage and ingredients. It specializes in solid dispersion development and lipid-or micro/nano-based emulsions. The company was founded in 1994 and is headquartered in Hunt Valley, MD.

Sunstar Deutschland GmbH provides oral care and health products. It products encompass toothbrushes, toothpaste and mouth sprays that offer solutions for tooth and gum problems. The company was founded in 1991 and is headquartered in Schonu, Germany.

BlueOcean Ventures SA (BlueOcean Ventures) is a venture capital firm founded in 2007 by Maurice Olivier, Faris Sabeti and Emmanuel de Watteville. The firm is headquartered in Geneva, Switzerland.

Ascendia Pharmaceuticals LLC engages in the invention and development of specialty pharmaceutical products and novel formulation technologies. It offers rapid development and special development programs. The company was founded by Jingjun Huang in 2012 and is headquartered in North Brunswick, NJ.

Volumina Medical SA develops tissue engineering technologies. Its platform AdiPearl, is the scaffold that solves the problem of natural repair of 3D soft tissues. The firm’s product is injectable through thin cannulas, reducing intervention time and recovery time. The company was founded by Amélie Béduer in 2017 and is headquartered in Lausanne, Switzerland.

EBAMed SA develops solutions for non-invasive and automated treatment of heart arrhythmias. The company was founded by Adriano Garonna and Leo Giovanni and is headquartered in Geneva, Switzerland.

Hylomorph AG is a medical technology company, which engages in the provision of optimal biocompatible barrier between soft tissues and implantable medical devices. It offers Hylomate Sheet, which separates a soft tissue implantable device from the surrounding tissue to reduce complications associated with fibrotic tissue encapsulation; and Hylomate Pouch, which provides long term protection of the surgical pocket tissue from fibrotic tissue build up. The company was founded by Simone Bottan and is headquartered in Zurich, Switzerland.

RK Pharma, Inc. develops, manufactures, and commercializes generic pharmaceutical products. The company is based in Pearl River, NY and has subsidiaries in the United States. The company was founded by Ravishanker Kovi. The CEO is George R. Thomas.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Eresearch Technologies, Inc. provides biopharmaceutical and healthcare research and drug development services.

Pharma Nobis, LLC manufactures pharmaceutical topical, transdermal creams, and syrups products. The private company is located in the US.

Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland.